Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates:: emm103 to emm124

被引:115
作者
Facklam, RF
Martin, DR
Lovgren, M
Johnson, DR
Efstratiou, A
Thompson, TA
Gowan, S
Kriz, P
Tyrrell, GJ
Kaplan, E
Beall, B
机构
[1] Ctr Dis Control & Prevent, WHO, Collaborating Ctr Streptococci, Atlanta, GA 30333 USA
[2] Univ Minnesota, WHO, Collaborating Ctr Reference & Res Streptocci, Minneapolis, MN USA
[3] Natl Ctr Streptococcus, Edmonton, AB, Canada
[4] Publ Hlth Lab Serv, Cent Publ Hlth Lab, WHO Collaborating Ctr Diphteria & Streptoccal Inf, Resp & System Infect Lab, London, England
[5] Natl Publ Hlth Inst, WHO, Collaborating Ctr Reference & Res Streptococci, Prague, Czech Republic
[6] Inst Environm Sci & Res Ltd, Porirua, New Zealand
关键词
D O I
10.1086/324621
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Classic M protein serotyping has been invaluable during the past 60 years for the determination of relationships between different group A streptococci (GAS) strains and the varied clinical manifestations inflicted by these organisms worldwide. Nonetheless, during the past 20 years, the difficulties of continued expansion of the serology-based Lancefield classification scheme for GAS have become increasingly apparent. By use of a less demanding sequence-based methodology that closely adheres to previously established strain criteria while being predictive of known M protein serotypes, we recently added types emm94-emm102 to the Lancefield scheme. Continued expansion by the addition of types emm103 to emm124 are now proposed. As with types emm94-emm102, each of these new emm types was represented by multiple independent isolates recovered from serious disease manifestations, each was M protein nontypeable with all typing sera stocks available to international GAS reference laboratories, and each demonstrated antiphagocytic properties in vitro by multiplying in normal human blood.
引用
收藏
页码:28 / 38
页数:11
相关论文
共 36 条